Skip to content

Vaginal Douching and Painting in Women Who Underwent Total Abdominal Hysterectomy

Vaginal Douching and Painting in Women Who Underwent Total Abdominal Hysterectomy: A Factorial 2-by-2 Open-labeled Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03537313
Enrollment
300
Registered
2018-05-25
Start date
2018-08-15
Completion date
2018-09-30
Last updated
2020-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile Morbidity

Brief summary

Comparison of the effectiveness of povidone-iodine douching and painting for reducing febrile morbidity after total abdominal hysterectomy

Detailed description

Total abdominal hysterectomy (TAH) is the most common gynecologic operation worldwide. The two most common complications after TAH are febrile and infectious morbidities, incidence varying between 5 and 50 percent. After performing TAH, vaginal canal must be breached and closed to be blind-pouch stump. Routing vaginal douching at the night before and on the morning of the surgical date, and intra-operative painting are routinely practiced. However, no good quality of evidence base supports the effectiveness of vaginal douching and painting in preventing febrile and infectious morbidities after TAH.

Interventions

PROCEDUREVagina douching

Vaginal douches with 1000 ml of 1% povidone-iodine solution on the night before surgery and again on the morning of surgery

PROCEDUREVagina painting

Vaginal painting of vagina stump after hysterectomy with 10% povidone-iodine solution 30 ml

Sponsors

Department of Medical Services Ministry of Public Health of Thailand
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Factorial 2-by-2 open labeled randomised controlled trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women who undergoing total abdominal hysterectomy * Woman who agrees to participate in this study

Exclusion criteria

* Women with history of sea-food or iodine allergy * Women who undergo emergency TAH * Women who have intestinal resection in this operation * Women who have active pelvic inflammatory disease before operation * Women who have fever before operation * Women who received antibiotic within 1 weeks before operation * Women who be immunocompromised host

Design outcomes

Primary

MeasureTime frameDescription
Febrile morbidityDay 1-7 after surgeryDefined as the presence of an oral temperature \> 38 o C (100.4 o F) on two occasions at least 4 hours apart in the post-operative period excluding the first 24 hours

Secondary

MeasureTime frameDescription
Vaginal cuff infection2 weeks after surgeryDefined as redness, tenderness, infiltration or abscess at vaginal cuff
Other infectious morbidities2 weeks after surgeryDefined by the presence of a urinary tract infection, abdominal wound infection, or pneumonitis; urinary tract infection defined as symptomatic infection with a mid-steam urine specimen showed bacterial growth \> 105 bacteria/ml of urine; surgical wound infection defined as redness, tenderness, infiltration or abscess; pneumonitis defined as fever, physical and radiological findings of consolidation

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026